The Muscular Dystrophy Association (MDA) brought its Engage Community Seminar to Hershey, Pennsylvania, on July 18, uniting ...

RAG-17 is an experimental RNA-targeting therapy designed to lower toxic SOD1 protein in people with SOD1-ALS. A six-person trial found RAG-17 was well tolerated, with no serious side effects. RAG-17 ...

Although I continue to rely on a rollator to help me walk inside the house and a mobility scooter when I’m out and about, getting the power wheelchair was a strategic, planning-ahead decision. I live ...

A PBS documentary, "Loving John," explores a gay American Samoan man's final years with ALS. It highlights the disease's ...

Study examines Qalsody safety after approval “This study is the first to systematically conduct a post-marketing [safety] ...

Over the last five years, Canadian ALS clinics have shifted from offering genetic testing mainly to people with a family ...

Preventing TDP-43 from forming toxic clumps is widely seen as a promising strategy for developing new ALS treatments. But it’s been difficult for scientists to find a way to prevent these clumps ...

While the findings align with previous research linking smoking to ALS, researchers found no consistent evidence that heavier ...

A self-balancing robotic exoskeleton was found safe and feasible for ALS patients with gait impairment. It helps patients practice walking hands-free, improving mobility, posture, and well-being.

While genetics alone do not cause amyotrophic lateral sclerosis (ALS), a large number of genetic mutations have been associated with the neurodegenerative disease. Such mutations can increase a person ...

Of all the scenes that stay in my mind from my late husband Jeff’s time with ALS, this is among the most enduring: Jeff, wearing a Navy baseball cap and a weathered T-shirt, sitting behind the console ...

An AI-powered brain implant helped an ALS patient regain speech by decoding brain signals. This neuroprosthesis translates ...